🔎 Trials Near Me

Akèy › Kansè trakt bilè › Distrik Columbia › Washington

Etid klinik pou Kansè trakt bilè nan Washington, DC

7 etid pou Kansè trakt bilè ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

Ap rekriteFaz 1/2
  • Sibley Memorial Hospital ( Site 0310), Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Oct 6, 2026 · NCT06428409

Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma

Ap rekriteEtid obsèvasyon
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 2 a 100 · Tout sèks · Mizajou Oct 2, 2026 · NCT01950572

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

Ap rekriteFaz 3
  • Research Site, Washington D.C.
  • Research Site, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07221253

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Ap rekriteFaz 1/2
  • Avenzo Therapeutics Recruiting Site, Washington D.C.
Laj 18 a 75 · Tout sèks · Mizajou Sep 4, 2026 · NCT07038343

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

Ap rekriteFaz 3
  • Research Site, Washington D.C.
Laj 18 a 99 · Tout sèks · Mizajou Aug 19, 2026 · NCT06467357

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • National Institutes of Health, Bethesda · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT05592626

A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)

Ap rekriteFaz 1/2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 120 · Tout sèks · Mizajou Mar 24, 2026 · NCT05849480

Etid Kansè trakt bilè nan lòt vil

Lòt etid nan Washington

Sous ClinicalTrials.gov, done yo ranmase Oct 7, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.